Medical Devices: Hong Kong IPO applicants (22 companies)
22 Medical Devices companies that have filed to list in Hong Kong, newest first, with what each does and links to its filings.
- 2026-09-03
Application ProofSHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.深圳信立泰药业股份有限公司Develops, produces, and sells pharmaceuticals and medical devices focused on cardiovascular-kidney-metabolic diseases in China, including innovative drugs, generics, and biosimilars. Ranked second in in-hospital sales of cardiovascular drugs in China in 2025 with an 11.3% market share, per Frost & Sullivan.
- 2026-08-28
ProspectusDevelops and manufactures medical devices across life support, minimally invasive intervention, and in vitro diagnostics, sold to hospitals, clinics, testing facilities and home care users in over 140 countries, with products reaching ~90% of China's Grade 3A hospitals.
- 2026-08-28
Application ProofNanjing Novlead Biotechnology Co., Ltd.南京诺令生物科技股份有限公司Develops and commercializes inhaled nitric oxide (iNO) therapy devices for cardiopulmonary indications in China, with core product iNOwill approved by NMPA in 2022 and CE-certified in 2025, serving ICU and critical care for severe cardiopulmonary disease.
- 2026-08-28
Application ProofHANGZHOU TANGJI MEDICAL TECHNOLOGY CO., LTD.杭州糖吉医疗科技股份有限公司Develops medical devices for treating and managing metabolic diseases in China, including a gastric bypass stent (DJBL) for obesity, two other registered products, a digital health management platform, and 13 pipeline products.
- 2026-06-22
ProspectusDevelops and commercializes percutaneous puncture and microwave ablation surgical robots for minimally invasive oncology care in China, with NMPA Class III registered puncture robots and ablation systems; ranked first in China's percutaneous puncture surgical robot market in 2025 with 28.0% revenue share, per CIC.
- 2026-05-27
Application ProofSino Medical Sciences Technology Inc.赛诺医疗科学技术股份有限公司Develops, manufactures and commercializes interventional medical devices for coronary, neurovascular, peripheral vascular, venous and structural heart diseases, selling in approximately 30 countries and regions. Per CIC, it has the most comprehensive innovative product portfolio among domestic Chinese companies in coronary and neurovascular intervention.
- 2026-05-27
Application ProofShanghai Simpletouch Robot Co., Ltd.上海睿触机器人股份有限公司Develops, produces and commercializes percutaneous puncture surgical robots and related navigation/positioning systems and consumables in China. Its RC120 robot, approved as a Class III medical device in 2024, ranked second in trial installations in China's percutaneous puncture surgical robot market, per CIC.
- 2026-05-15
Application ProofShandong Ande Healthcare Apparatus Co., Ltd.山东安得医疗用品股份有限公司Develops and manufactures medical consumables in China, including drug delivery, vascular access, blood specimen collection, interventional, surgical and medical imaging consumable products, sold to medical institutions across multiple clinical departments.
- 2026-05-14
Application ProofDevelops and commercializes molecular diagnostic instruments and biochips in China, offering a microarray analyzer, EL-NGS gene sequencers, and compatible test kits. Its core product AxiLona EL-100 performs electrochemistry-based, multi-target nucleic acid detection.
- 2026-05-11
Application ProofShenzhen Mindray Bio-Medical Electronics Co., Ltd.深圳迈瑞生物医疗电子股份有限公司Develops and manufactures medical devices including IVD, patient monitoring and life support, medical imaging, and minimally invasive surgery products, sold globally across clinical settings. Ranked No.1 among China's domestic medical device companies by revenue and No.23 globally in 2024, per Frost & Sullivan.
- 2026-04-27
ProspectusProvides home care medical devices in China, including home rehabilitation aids, respiratory support products, and medical care supplies under multiple brands, with over 200 product types. Ranked second among home care medical devices providers in China with 2.1% market share in 2024, per Frost & Sullivan.
- 2026-04-24
ProspectusDevelops and sells sports medicine implants, instruments, active equipment and medical consumables for treating and rehabilitating sports-related soft tissue injuries in China. Fourth largest sports medicine implants and instruments provider in China with ~6.5% market share, and largest domestic provider, per CIC (2024).
- 2026-04-15
Application ProofAnnoroad Gene Technology (Beijing) Co., Ltd.安诺优达基因科技（北京）股份有限公司Develops genetic-sequencing-based IVD medical devices and life sciences research services in China, including NIPT and CNV-seq Class III test kits for fetal genetic anomaly detection, the NextSeq 550AR sequencer, and bioinformatics software, sold to hospitals and independent clinical laboratories.
- 2026-04-10
Application ProofGOOD DOCTOR CLOUD HEALTHCARE & TECHNOLOGY GROUP CO., LTD.四川好医生云医疗科技集团股份有限公司Provides services to primary healthcare terminals in China, including pharmaceutical direct supply and integrated testing, diagnosis and treatment solutions for primary healthcare institutions in lower-tier markets. Ranked second in pharmaceutical direct supply to primary healthcare in China by 2024 revenue, per CIC.
- 2026-04-07
Application ProofWuhan Ammunition Life-tech Co., Ltd.武汉艾米森生命科技股份有限公司Develops methylation-based early cancer detection assays, including a qPCR liver cancer test and a non-invasive urine test for urothelial cancer, with four additional candidates in the pipeline.
- 2026-03-20
ProspectusDevelops medical imaging products and services in China, including AI-assisted chromosome karyotyping diagnostic software, medical imaging devices, reagents and consumables, and technology licensing, serving prenatal diagnosis and assisted reproduction fields.
- 2026-02-27
Application ProofManufactures and sells dental materials, including clinical, laboratory, and digital dental products, to dental hospitals, clinics, and laboratories in China through distributors, with expanding international sales. Largest dental impression materials manufacturer in China (1.3% share of China dental material market in 2024).
- 2025-12-30
ProspectusDevelops and manufactures surgical robots for minimally invasive and non-invasive surgery, including multi-port and single-port endoscopic surgical robots and a bronchoscope robot, covering urologic, gynecologic, general and thoracic applications. Founded in 2017, based in China.
- 2025-05-15
ProspectusMirxes Holding Company Limited02629.HKDevelops blood-based miRNA in vitro diagnostic products for disease screening in Asia, headquartered in Singapore. Its core product, GASTROClear, is a 12-biomarker blood test for gastric cancer screening, commercialized in Singapore with HSA Class C IVD certification.
- 2024-12-30
ProspectusDevelops software-based digital therapeutics and screening/assessment products for cognitive impairments caused by vascular, neurodegenerative and psychiatric disorders and child developmental deficiencies, with regulatory approvals in China and the EU.
- 2024-11-20
ProspectusBiopharmaceutical company in Zhejiang, China engaged in R&D, manufacturing and commercialization of biopharmaceutical products and medical devices, focused on orthopedics, metabolic diseases, oncology and hematology; has eight marketed products including China's first rhBMP-2 bone repair material.
- 2023-12-29
ProspectusProvides oncology healthcare services in China through six self-owned medical institutions, including cancer hospitals, clinics and an imaging center, serving cancer patients, and sells and installs oncology-related medical equipment and software to hospitals. Holds 0.5% share of China's private oncology healthcare market (per F&S Report, 2022).